Analysts: MasterCard Reports In-Line Q3 Revenue and 3 More Research Notes to Read
MasterCard Inc. (NYSE:MA): Barclays expects MasterCard to report in-line third-quarter revenue growth and a modest potential earnings per share upside; the firm continues to see strong secular trends and raised its price target to $830 from $705, given better visibility around 2015 estimates. The analyst rated MasterCard stock Overweight.
Celgene Corp. (NASDAQ:CELG): Argus increased its price target on Celgene to $175 from $160 after the company reported stronger-than-expected third-quarter results; the firm notes that the company’s two key new products — Abraxane for cancer and Pomalyst for myeloma — generated strong revenue growth in the last quarter. The firm keeps a Buy rating on Celgene stock.
GameStop Corp. (NYSE:GME): SunTrust believes that GameStop is poised to have a successful holiday season, noting that consumers are very interested in new consoles even while estimates for the company are conservative. The firm believes the stock’s multiple has room for expansion, and the analyst increased its price target on GameStop shares to $70 from $65, keeping a Buy rating on the stock.
Safeway Inc. (NYSE:SWY): BB&T’s sum of the parts analysis indicates that Safeway could sell itself for $47 per share in a takeover scenario. If, however, the company was to sell only its bad and mediocre assets, a sum of the parts analysis indicates that the stock would be worth $42 per share; nonetheless, the firm adds that this scenario could create greater value for shareholders over the long term, and the analyst keeps a Buy rating on Safeway stock.